MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 186 filers reported holding MYRIAD GENETICS INC in Q2 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,043 | -30.8% | 65 | 0.0% | 0.00% | – |
Q2 2023 | $1,507 | -0.2% | 65 | 0.0% | 0.00% | – |
Q1 2023 | $1,510 | +60.1% | 65 | 0.0% | 0.00% | – |
Q4 2022 | $943 | -52.8% | 65 | -22.6% | 0.00% | – |
Q3 2022 | $2,000 | 0.0% | 84 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | 0.0% | 84 | 0.0% | 0.00% | – |
Q1 2022 | $2,000 | 0.0% | 84 | 0.0% | 0.00% | – |
Q4 2021 | $2,000 | – | 84 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |